Direct effect of dasatinib on proliferation and cytotoxicity of natural killer cells inin vitrostudy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Direct effect of dasatinib on proliferation and cytotoxicity of natural killer cells inin vitrostudy

Published:2012-10-29 Issue:3 Volume:31 Page:156-163
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematol Oncol

Author:

Uchiyama Takayoshi¹,Sato Naoya¹,Narita Miwako¹,Yamahira Akie¹,Iwabuchi Minami¹,Furukawa Tatsuo²,Sone Hirohito²,Takahashi Masuhiro¹

Affiliation:

1. Laboratory of Hematology and Oncology, Graduate School of Health Sciences; Niigata University; Niigata Japan

2. Division of Hematology, Endocrinology and Metabolism; Department of Internal Medicine, Faculty of Medicine, Niigata University; Niigata Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hon.2034/fullpdf

Reference26 articles.

1. Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy;Mustjoki;Leukemia,2009

2. Retrospective multicenter study on the development of peripheral lymphocytosis following second-line dasatinib therapy for chronic myeloid leukemia;Lee;Am J Hematol,2011

3. Mono/oligoclonal T and NK cells are common in chronic myeloid leukemia patients at diagnosis and expand during dasatinib therapy;Kreutzman;Blood,2010

4. Expansion of highly differentiated CD8(+) T-cells or NK-cells in patients treated with asatinib is associated with cytomegalovirus reactivation;Kreutzman;Leukemia,2011

5. Natural killer or natural killer/T cell lineage large granular lymphocytosis associated with dasatinib therapy for Philadelphia chromosome positive leukemia;Kim;Haematologica,2009

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the tumor microenvironment for treating double-refractory chronic lymphocytic leukemia;Blood;2024-08-08

2. Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against Cancer;Vaccines;2022-11-23

3. Back to the Future: Spatiotemporal Determinants of NK Cell Antitumor Function;Frontiers in Immunology;2022-01-10

4. Therapeutic Drug Monitoring and Individualized Medicine of Dasatinib: Focus on Clinical Pharmacokinetics and Pharmacodynamics;Frontiers in Pharmacology;2021-12-06

5. NK Cells in Myeloproliferative Neoplasms (MPN);Cancers;2021-08-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3